EUVIMEDEUVIMED entdecken
Crossref

The burden of secondary antibiotic resistance in Helicobacter pylori in Auckland, Aotearoa New Zealand

Cameron Schauer, Marius van Rijnsoever, Susan Taylor, Michael Tm Wang, Russell Walmsley, Jonathan Koea, Stephen Inns, Tom Hills

New Zealand Medical Journal · 17.04.2026 · 139 (1633) · 55-65

DOI: 10.26635/6965.7351 ↗

Kurz gefasst

Fachartikel in der Zeitschrift New Zealand Medical Journal, online erschienen am 17.04.2026. Verfasst von Cameron Schauer und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Health New Zealand - Te Whatu Ora Waitematā; The University of Auckland, Auckland. Hauptthemen laut MEDLINE: Helicobacter pylori, Helicobacter Infections, Anti-Bacterial Agents, Drug Resistance, Bacterial.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

aim: Helicobacter pylori (H. pylori) infection is the principle modifiable risk factor for gastric cancer and a key driver of ethnic disparities in gastric disease within Aotearoa New Zealand. Increasing antibiotic resistance threatens eradication success, yet secondary resistance patterns have not previously been described in New Zealand. This study aimed to describe, for the first time, secondary H. pylori antibiotic resistance rates in New Zealand and identify demographic predictors to inform eradication strategies. methods: A retrospective review was conducted of H. pylori isolates referred for antibiotic susceptibility testing in Auckland between January 2018 and December 2023. Testing was performed at Middlemore Hospital Laboratory using gradient diffusion minimum inhibitory concentration (MIC) strips for amoxicillin, clarithromycin, metronidazole and tetracycline. Demographic data were obtained from the Auckland TestSafe database and analysed using univariate and multivariable logistic regression. results: Of 3,234 patients tested, 644 (20%) were culture positive. Resistance rates were clarithromycin 68%, metronidazole 68.5%, amoxicillin 2.5% and tetracycline 0%. Male sex was associated with lower odds of metronidazole resistance (p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Helicobacter pyloriHelicobacter InfectionsAnti-Bacterial AgentsDrug Resistance, BacterialHumansNew ZealandMaleRetrospective StudiesFemaleMiddle AgedClarithromycinMicrobial Sensitivity TestsMetronidazoleTetracyclineAmoxicillinAdultMaori PeopleAged

Substanzen

Anti-Bacterial AgentsClarithromycinMetronidazoleTetracyclineAmoxicillin

Autor:innen und Institutionen

  • Department of Gastroenterology, Health New Zealand - Te Whatu Ora Waitematā; The University of Auckland, Auckland.
  • Department of Gastroenterology, Health New Zealand - Te Whatu Ora Waitematā.
  • Middlemore Hospital Laboratory, Health New Zealand - Te Whatu Ora Counties Manukau.
  • Faculty of Medicine, The University of Auckland, Auckland.
  • Department of Surgery, Health New Zealand - Te Whatu Ora Waitematā; The University of Auckland, Auckland.
  • Department of Medicine, University of Otago, Wellington; Health New Zealand - Te Whatu Ora Capital Coast and Hutt Valley; Department of Gastroenterology, Hutt Hospital, Lower Hutt.

Zitieren

APA

Schauer, C., van Rijnsoever, M., Taylor, S., Wang, M. T., Walmsley, R., Koea, J., Inns, S., & Hills, T. (2026). The burden of secondary antibiotic resistance in Helicobacter pylori in Auckland, Aotearoa New Zealand. New Zealand Medical Journal, 139(1633), 55-65. https://doi.org/10.26635/6965.7351

Vancouver

Schauer C, van Rijnsoever M, Taylor S, Wang MT, Walmsley R, Koea J, et al. The burden of secondary antibiotic resistance in Helicobacter pylori in Auckland, Aotearoa New Zealand. New Zealand Medical Journal. 2026;139(1633):55-65. doi:10.26635/6965.7351

BibTeX
@article{Schauer2026,
  author = {Schauer, Cameron and van Rijnsoever, Marius and Taylor, Susan and Wang, Michael Tm and Walmsley, Russell and Koea, Jonathan and Inns, Stephen and Hills, Tom},
  title = {The burden of secondary antibiotic resistance in Helicobacter pylori in Auckland, Aotearoa New Zealand},
  journal = {New Zealand Medical Journal},
  year = {2026},
  volume = {139},
  number = {1633},
  pages = {55--65},
  doi = {10.26635/6965.7351}
}
Kostenlos starten →